107 related articles for article (PubMed ID: 25158572)
41. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
[TBL] [Abstract][Full Text] [Related]
42. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin.
Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H
Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009
[TBL] [Abstract][Full Text] [Related]
43. Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Aberg M; Wickström M; Siegbahn A
Thromb Res; 2008; 122(2):191-202. PubMed ID: 18031796
[TBL] [Abstract][Full Text] [Related]
44. Protective effect of curcumin against formaldehyde-induced genotoxicity in A549 Cell Lines.
Zhang BY; Shi YQ; Chen X; Dai J; Jiang ZF; Li N; Zhang ZB
J Appl Toxicol; 2013 Dec; 33(12):1468-73. PubMed ID: 23059809
[TBL] [Abstract][Full Text] [Related]
45. Simvastatin and oxidative stress in humans: A randomized, double-blinded, placebo-controlled clinical trial.
Rasmussen ST; Andersen JT; Nielsen TK; Cejvanovic V; Petersen KM; Henriksen T; Weimann A; Lykkesfeldt J; Poulsen HE
Redox Biol; 2016 Oct; 9():32-38. PubMed ID: 27281490
[TBL] [Abstract][Full Text] [Related]
46. Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients.
Chang JW; Yang WS; Min WK; Lee SK; Park JS; Kim SB
Am J Kidney Dis; 2002 Jun; 39(6):1213-7. PubMed ID: 12046033
[TBL] [Abstract][Full Text] [Related]
47. Simvastatin induces breast cancer cell death through oxidative stress up-regulating miR-140-5p.
Bai F; Yu Z; Gao X; Gong J; Fan L; Liu F
Aging (Albany NY); 2019 May; 11(10):3198-3219. PubMed ID: 31138773
[TBL] [Abstract][Full Text] [Related]
48. Long-term simvastatin attenuates lung injury and oxidative stress in murine acute lung injury models induced by oleic Acid and endotoxin.
Altintas ND; Atilla P; Iskit AB; Topeli A
Respir Care; 2011 Aug; 56(8):1156-63. PubMed ID: 21396178
[TBL] [Abstract][Full Text] [Related]
49. The role of oxidative stress in hormesis induced by sodium arsenite in human embryo lung fibroblast (HELF) cellular proliferation model.
Yang P; He XQ; Peng L; Li AP; Wang XR; Zhou JW; Liu QZ
J Toxicol Environ Health A; 2007 Jun; 70(11):976-83. PubMed ID: 17479414
[TBL] [Abstract][Full Text] [Related]
50. Simvastatin attenuates intestinal ischemia/reperfusion induced injury in rat.
Hajipour B; Somi MH; Saberifar F; Hemmati MR; Asl NA; Moein A; Vatankhah AM; Nourazar AR; Nasirizade MR
Folia Morphol (Warsz); 2009 Aug; 68(3):156-62. PubMed ID: 19722159
[TBL] [Abstract][Full Text] [Related]
51. Statins Prevent Dextrose-Induced Endoplasmic Reticulum Stress and Oxidative Stress in Endothelial and HepG2 Cells.
Kojanian H; Szafran-Swietlik A; Onstead-Haas LM; Haas MJ; Mooradian AD
Am J Ther; 2016; 23(6):e1456-e1463. PubMed ID: 24800792
[TBL] [Abstract][Full Text] [Related]
52. Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease.
Hillyard DZ; Cameron AJ; McDonald KJ; Thomson J; MacIntyre A; Shiels PG; Panarelli M; Jardine AG
Atherosclerosis; 2004 Aug; 175(2):305-13. PubMed ID: 15262187
[TBL] [Abstract][Full Text] [Related]
53. Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells.
Borahay MA; Kilic GS; Yallampalli C; Snyder RR; Hankins GD; Al-Hendy A; Boehning D
J Biol Chem; 2014 Dec; 289(51):35075-86. PubMed ID: 25359773
[TBL] [Abstract][Full Text] [Related]
54. Simvastatin is effective in killing the radioresistant breast carcinoma cells.
Aschenbrenner B; Negro G; Savic D; Sorokin M; Buzdin A; Ganswindt U; Cemazar M; Sersa G; Skvortsov S; Skvortsova I
Radiol Oncol; 2021 May; 55(3):305-316. PubMed ID: 33939900
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxicity of Simvastatin in Human Breast Cancer MCF-7 and MDA-MB-231 Cell Lines.
Rezano A; Ridhayanti F; Rangkuti AR; Gunawan T; Winarno GNA; Wijaya I
Asian Pac J Cancer Prev; 2021 Feb; 22(S1):33-42. PubMed ID: 33576210
[TBL] [Abstract][Full Text] [Related]
56. Simvastatin downregulates expression of TGF-βRII and inhibits proliferation of A549 cells via ERK.
Shang L; Jia SS; Jiang HM; Wang H; Xu WH; Lv CJ
Tumour Biol; 2015 Jun; 36(6):4819-24. PubMed ID: 25631750
[TBL] [Abstract][Full Text] [Related]
57. Simvastatin suppresses breast cancer cell proliferation induced by senescent cells.
Liu S; Uppal H; Demaria M; Desprez PY; Campisi J; Kapahi P
Sci Rep; 2015 Dec; 5():17895. PubMed ID: 26658759
[TBL] [Abstract][Full Text] [Related]
58. Mitochondrial protection by simvastatin against angiotensin II-mediated heart failure.
Hsieh CC; Li CY; Hsu CH; Chen HL; Chen YH; Liu YP; Liu YR; Kuo HF; Liu PL
Br J Pharmacol; 2019 Oct; 176(19):3791-3804. PubMed ID: 31265743
[TBL] [Abstract][Full Text] [Related]
59. Biological Effects of Simvastatin Formulated as pMDI on Pulmonary Epithelial Cells.
Tulbah AS; Ong HX; Lee WH; Colombo P; Young PM; Traini D
Pharm Res; 2016 Jan; 33(1):92-101. PubMed ID: 26238046
[TBL] [Abstract][Full Text] [Related]
60. Simvastatin promotes endothelial dysfunction by activating the Wnt/β‑catenin pathway under oxidative stress.
He Z; Du X; Wu Y; Hua L; Wan L; Yan N
Int J Mol Med; 2019 Oct; 44(4):1289-1298. PubMed ID: 31432100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
